Clinical Trial Update: Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine Tumors [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update on the investigational agent BL-M14D1 for locally advanced or metastatic small cell lung cancer and a range of neuroendocrine tumo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extrapulmonary Neuroendocrine Carcinoma
• Gastroenteropancreatic Neuroendocrine Carcinoma
• Large Cell Neuroendocrine Carcinoma of the Lung
• Merkel Cell Carcinoma
• Neuroendocrine Carcinoma
• Neuroendocrine Tumor
• Prostate Neuroendocrine Carcinoma
• Small Cell Lung Cancer

Drugs mentioned

• BL-M14D1

Snippet

Sponsor: SystImmune Inc. | Conditions: Small Cell Lung Cancer Metastatic or Locally Advanced, Neuroendocrine Cancer | Phase 1 | Status: RECRUITING